Importer of Controlled Substances Application: Usona Institute, 64365 [2018-27133]
Download as PDF
<![CDATA[
64365
Federal Register / Vol. 83, No. 240 / Friday, December 14, 2018 / Notices
958, to the DEA Administrator, 28 CFR
0.100(b). Authority to exercise all
necessary functions with respect to the
promulgation and implementation of 21
CFR part 1301, incident to the
registration of manufacturers,
distributors, dispensers, importers, and
exporters of controlled substances (other
than final orders in connection with
suspension, denial, or revocation of
registration) has been delegated to the
Assistant Administrator of the DEA
Diversion Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
Therefore, in accordance with 21
U.S.C. 958(i) and 21 CFR 1301.34(a),
this is notice that on June 11, 2018,
Arizona Department of Corrections,
1305 E Butte Avenue, ASPC-Florence,
Florence, Arizona 85132–9221, reapplied to be registered as an importer
of Pentobarbital (2270), a basic class of
the controlled substance listed in
schedule II.
The facility intends to import the
above-listed controlled substance for
legitimate use. This particular
controlled substance is not available for
the intended legitimate use within the
current domestic supply of the United
States.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture this
basic class of controlled substance may
file comments or objections to the
issuance of the proposed registration or
to the authorization of this importation,
and may, at the same time, file a written
request for a hearing. Any such
comments, objections, or hearing
requests should be addressed as
described above.
Dated: December 4, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–27131 Filed 12–13–18; 8:45 am]
BILLING CODE 4410–09–P
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on October
31, 2018, Usona Institute, 2800 Woods
Hollow Road, Madison, Wisconsin
53711 applied to be registered as an
importer of the following basic classes
of controlled substances:
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Usona Institute
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 14, 2019. Such
persons may also file a written request
for a hearing on the application on or
before January 14, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
DATES:
Controlled substance
Drug code
5-Methoxy-N-N-dimethyltryptamine .................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
The institute plans to import the
listed controlled substances for
potential formulation development for
substances to be used in institutesponsored research.
Dated: December 4, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–27133 Filed 12–13–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
OMB Number 1117–0008]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection; Application for
Procurement Quota for Controlled
Substance and for Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine; DEA Form 250
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day Notice.
amozie on DSK3GDR082PROD with NOTICES1
AGENCY:
The Department of Justice,
Drug Enforcement Administration
(DEA), will be submitting the following
information collection request to the
Office of Management and Budget for
SUMMARY:
VerDate Sep<11>2014
16:57 Dec 13, 2018
Jkt 247001
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
7431
7435
Schedule
I
I
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
February 12, 2019.
FOR FURTHER INFORMATION CONTACT: If
you have comments, especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Kathy L. Federico, Diversion
Control Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
E:\FR\FM\14DEN1.SGM
14DEN1
]]>Agencies
[Federal Register Volume 83, Number 240 (Friday, December 14, 2018)]
[Notices]
[Page 64365]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27133]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Usona Institute
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before January 14, 2019.
Such persons may also file a written request for a hearing on the
application on or before January 14, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on
October 31, 2018, Usona Institute, 2800 Woods Hollow Road, Madison,
Wisconsin 53711 applied to be registered as an importer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
5-Methoxy-N-N-dimethyltryptamine......... 7431 I
Dimethyltryptamine....................... 7435 I
------------------------------------------------------------------------
The institute plans to import the listed controlled substances for
potential formulation development for substances to be used in
institute-sponsored research.
Dated: December 4, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-27133 Filed 12-13-18; 8:45 am]
BILLING CODE 4410-09-P
